Cargando…
TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases
Breast cancer (BCa) cells disseminating to the bone can remain dormant and resistant to treatments for many years until relapsing as bone metastases. The tyrosine kinase receptor TIE2 induces the dormancy of hematopoietic stem cells, and could also induce the dormancy of BCa cells. However, TIE2 is...
Autores principales: | Drescher, Florian, Juárez, Patricia, Arellano, Danna L., Serafín-Higuera, Nicolás, Olvera-Rodriguez, Felipe, Jiménez, Samanta, Licea-Navarro, Alexei F., Fournier, Pierrick G.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226250/ https://www.ncbi.nlm.nih.gov/pubmed/32260072 http://dx.doi.org/10.3390/cancers12040868 |
Ejemplares similares
-
Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice
por: Arellano, Danna L., et al.
Publicado: (2022) -
Ra223 in Bone Metastases with Osteolytic Activity
por: Costa, Renato Patrizio, et al.
Publicado: (2018) -
Prostate adenocarcinoma with osteolytic metastases: Case report and review of the literature
por: Rummel, Keaton, et al.
Publicado: (2021) -
Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases
por: Das, Shamik, et al.
Publicado: (2012) -
Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases
por: McCarty, Mark F., et al.
Publicado: (2016)